A groundbreaking study published in The Lancet has revealed promising results for the use of stem-cell-derived corneal implants in restoring vision for patients suffering from limbal stem cell deficiency (LSCD). This condition, which leads to significant vision impairment due to the loss of corneal
Comprehensive Genomic Profiling (CGP) is revolutionizing cancer treatment by enabling early detection and personalized therapy. A recent study published in the Journal of Clinical Oncology - Oncology Practice (JCO-OP) highlights the significant benefits of early CGP testing in improving clinical
In the realm of medical diagnostics, a groundbreaking genomic test is making waves by leveraging DNA and RNA sequencing to identify a wide array of pathogens. Developed at the University of California, San Francisco (UCSF), this innovative technology is poised to revolutionize the way we diagnose
A new partnership between two powerhouses in the pharmaceutical industry promises substantial advancements in drug discovery and development. Novartis, one of the largest pharmaceutical companies globally, will pay Schrödinger $150 million upfront to utilize its advanced computing tools and
The field of regenerative medicine has seen remarkable advancements over the past few decades, with stem cell therapies emerging as a promising frontier. These therapies hold the potential to revolutionize the treatment of a wide array of diseases and conditions by harnessing the body's own repair
In a strategic move aimed at ensuring the utmost safety and efficacy, the US Food and Drug Administration (FDA) has recently announced a three-month delay in the priority review of Neurotech Pharmaceuticals' NT-501 eye cell therapy implant. This extension shifts the anticipated action date to March
